Final answer:
Option D, turning our genes into commercial profits, is not considered a social or ethical issue raised by genetic testing; instead, it refers to potential business implications. The correct ethical and social concerns include misconceptions of genetics, confidentiality and consent issues, and difficulties in understanding genetic testing results. These points emphasize the need for ongoing societal dialogue on genetic privacy, discrimination, and use of genetic data.
Step-by-step explanation:
The question 'Which of the following is NOT an issue raised by genetic testing?' refers to various concerns associated with genetic testing. Among the options provided, turning our genes (data) into commercial profits is NOT typically framed as an ethical or social issue, but rather a consequence of how genetic data might be utilized in the business sphere. Therefore, option D is not an ethical or social issue, unlike problems posed by public misconceptions of genetics, problems with confidentiality & consent, and problems with understanding genetic testing results, which directly relate to ethical and social concerns.
Challenges in genetic testing encompass privacy issues, where there are concerns about who controls genetic information. The ethical use of genome information implicates several questions: Should genome sequencing be mandatory? Can refusal impact insurance coverage? What policies should regulate the use of genetic data? The Genetic Information Nondiscrimination Act of 2008 (GINA) aims to curb discriminatory practices but doesn't cover all insurance types, highlighting gaps that society must address.
Moreover, with genetic testing, we face potential discrimination based on genetics, posing numerous legal issues to do with health and privacy rights. Finally, there is the overarching responsibility we carry to ensure that we use genetic knowledge wisely, to improve healthcare and respect individual rights rather than misusing it.